{"id":85313,"date":"2025-06-01T03:12:05","date_gmt":"2025-06-01T03:12:05","guid":{"rendered":"https:\/\/exam.pscnotes.com\/mcq\/?p=85313"},"modified":"2025-06-01T03:12:05","modified_gmt":"2025-06-01T03:12:05","slug":"consider-the-following-pairs-of-vaccine-and-category-type-1-covax","status":"publish","type":"post","link":"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/","title":{"rendered":"Consider the following pairs of vaccine and category\/type:\n \n 1. Covax"},"content":{"rendered":"<p>Consider the following pairs of vaccine and category\/type:<\/p>\n<ul>\n<li>1. Covaxin : Inactivated pathogen-based vaccine<\/li>\n<li>2. Covishield : mRNA vaccine<\/li>\n<li>3. Sputnik V : Viral vector-based vaccine<\/li>\n<\/ul>\n<p>Which of the pairs given above is\/are correctly matched ?<\/p>\n<p>[amp_mcq option1=&#8221;1 only&#8221; option2=&#8221;2 and 3 only&#8221; option3=&#8221;1 and 3 only&#8221; option4=&#8221;1, 2 and 3&#8243; correct=&#8221;option3&#8243;]<\/p>\n<div class=\"psc-box-pyq-exam-year-detail\">\n<div class=\"pyq-exam\">\n<div class=\"psc-heading\">This question was previously asked in<\/div>\n<div class=\"psc-title line-ellipsis\">UPSC CDS-1 &#8211; 2022<\/div>\n<\/div>\n<div class=\"pyq-exam-psc-buttons\"><a href=\"\/pyq\/pyq-upsc-cds-1-2022.pdf\" target=\"_blank\" class=\"psc-pdf-button\" rel=\"noopener\">Download PDF<\/a><a href=\"\/pyq-upsc-cds-1-2022\" target=\"_blank\" class=\"psc-attempt-button\" rel=\"noopener\">Attempt Online<\/a><\/div>\n<\/div>\n<section id=\"pyq-correct-answer\">\nPairs 1 and 3 are correctly matched regarding the vaccine type, while pair 2 is incorrect.<br \/>\n<\/section>\n<section id=\"pyq-key-points\">\n&#8211; Covaxin, developed by Bharat Biotech in India, is an inactivated vaccine. It uses a killed version of the SARS-CoV-2 virus to trigger an immune response.<br \/>\n&#8211; Covishield, manufactured by Serum Institute of India, is a viral vector vaccine. It uses a modified adenovirus (a common cold virus) to deliver genetic material of the SARS-CoV-2 spike protein into cells, prompting an immune response. It is not an mRNA vaccine.<br \/>\n&#8211; Sputnik V, developed by the Gamaleya Research Institute in Russia, is also a viral vector vaccine, using two different adenoviruses (Ad26 and Ad5) for the two doses.<br \/>\n<\/section>\n<section id=\"pyq-additional-information\">\n&#8211; mRNA vaccines (like Pfizer-BioNTech and Moderna) use messenger RNA to instruct cells to make a piece of the virus&#8217;s spike protein, triggering an immune response.<br \/>\n&#8211; Viral vector vaccines (like AstraZeneca\/Covishield, Sputnik V, and Johnson &#038; Johnson) use a harmless virus to deliver genetic instructions for making the spike protein.<br \/>\n&#8211; Inactivated vaccines (like Covaxin, Sinovac, Sinopharm) use killed viral particles.<br \/>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Consider the following pairs of vaccine and category\/type: 1. Covaxin : Inactivated pathogen-based vaccine 2. Covishield : mRNA vaccine 3. Sputnik V : Viral vector-based vaccine Which of the pairs given above is\/are correctly matched ? [amp_mcq option1=&#8221;1 only&#8221; option2=&#8221;2 and 3 only&#8221; option3=&#8221;1 and 3 only&#8221; option4=&#8221;1, 2 and 3&#8243; correct=&#8221;option3&#8243;] This question was &#8230; <\/p>\n<p class=\"read-more-container\"><a title=\"Consider the following pairs of vaccine and category\/type:\n \n 1. Covax\" class=\"read-more button\" href=\"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/#more-85313\">Detailed Solution<span class=\"screen-reader-text\">Consider the following pairs of vaccine and category\/type:<\/p>\n<p> 1. Covax<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1087],"tags":[1108,1117,1146],"class_list":["post-85313","post","type-post","status-publish","format-standard","hentry","category-upsc-cds-1","tag-1108","tag-biology","tag-genetic-engineering-and-biotechnology","no-featured-image-padding"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.2 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Consider the following pairs of vaccine and category\/type:  1. Covax<\/title>\n<meta name=\"description\" content=\"Pairs 1 and 3 are correctly matched regarding the vaccine type, while pair 2 is incorrect. - Covaxin, developed by Bharat Biotech in India, is an inactivated vaccine. It uses a killed version of the SARS-CoV-2 virus to trigger an immune response. - Covishield, manufactured by Serum Institute of India, is a viral vector vaccine. It uses a modified adenovirus (a common cold virus) to deliver genetic material of the SARS-CoV-2 spike protein into cells, prompting an immune response. It is not an mRNA vaccine. - Sputnik V, developed by the Gamaleya Research Institute in Russia, is also a viral vector vaccine, using two different adenoviruses (Ad26 and Ad5) for the two doses.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Consider the following pairs of vaccine and category\/type:  1. Covax\" \/>\n<meta property=\"og:description\" content=\"Pairs 1 and 3 are correctly matched regarding the vaccine type, while pair 2 is incorrect. - Covaxin, developed by Bharat Biotech in India, is an inactivated vaccine. It uses a killed version of the SARS-CoV-2 virus to trigger an immune response. - Covishield, manufactured by Serum Institute of India, is a viral vector vaccine. It uses a modified adenovirus (a common cold virus) to deliver genetic material of the SARS-CoV-2 spike protein into cells, prompting an immune response. It is not an mRNA vaccine. - Sputnik V, developed by the Gamaleya Research Institute in Russia, is also a viral vector vaccine, using two different adenoviruses (Ad26 and Ad5) for the two doses.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/\" \/>\n<meta property=\"og:site_name\" content=\"MCQ and Quiz for Exams\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-01T03:12:05+00:00\" \/>\n<meta name=\"author\" content=\"rawan239\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rawan239\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Consider the following pairs of vaccine and category\/type:  1. Covax","description":"Pairs 1 and 3 are correctly matched regarding the vaccine type, while pair 2 is incorrect. - Covaxin, developed by Bharat Biotech in India, is an inactivated vaccine. It uses a killed version of the SARS-CoV-2 virus to trigger an immune response. - Covishield, manufactured by Serum Institute of India, is a viral vector vaccine. It uses a modified adenovirus (a common cold virus) to deliver genetic material of the SARS-CoV-2 spike protein into cells, prompting an immune response. It is not an mRNA vaccine. - Sputnik V, developed by the Gamaleya Research Institute in Russia, is also a viral vector vaccine, using two different adenoviruses (Ad26 and Ad5) for the two doses.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/","og_locale":"en_US","og_type":"article","og_title":"Consider the following pairs of vaccine and category\/type:  1. Covax","og_description":"Pairs 1 and 3 are correctly matched regarding the vaccine type, while pair 2 is incorrect. - Covaxin, developed by Bharat Biotech in India, is an inactivated vaccine. It uses a killed version of the SARS-CoV-2 virus to trigger an immune response. - Covishield, manufactured by Serum Institute of India, is a viral vector vaccine. It uses a modified adenovirus (a common cold virus) to deliver genetic material of the SARS-CoV-2 spike protein into cells, prompting an immune response. It is not an mRNA vaccine. - Sputnik V, developed by the Gamaleya Research Institute in Russia, is also a viral vector vaccine, using two different adenoviruses (Ad26 and Ad5) for the two doses.","og_url":"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/","og_site_name":"MCQ and Quiz for Exams","article_published_time":"2025-06-01T03:12:05+00:00","author":"rawan239","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rawan239","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/","url":"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/","name":"Consider the following pairs of vaccine and category\/type: 1. Covax","isPartOf":{"@id":"https:\/\/exam.pscnotes.com\/mcq\/#website"},"datePublished":"2025-06-01T03:12:05+00:00","dateModified":"2025-06-01T03:12:05+00:00","author":{"@id":"https:\/\/exam.pscnotes.com\/mcq\/#\/schema\/person\/5807dafeb27d2ec82344d6cbd6c3d209"},"description":"Pairs 1 and 3 are correctly matched regarding the vaccine type, while pair 2 is incorrect. - Covaxin, developed by Bharat Biotech in India, is an inactivated vaccine. It uses a killed version of the SARS-CoV-2 virus to trigger an immune response. - Covishield, manufactured by Serum Institute of India, is a viral vector vaccine. It uses a modified adenovirus (a common cold virus) to deliver genetic material of the SARS-CoV-2 spike protein into cells, prompting an immune response. It is not an mRNA vaccine. - Sputnik V, developed by the Gamaleya Research Institute in Russia, is also a viral vector vaccine, using two different adenoviruses (Ad26 and Ad5) for the two doses.","breadcrumb":{"@id":"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/exam.pscnotes.com\/mcq\/consider-the-following-pairs-of-vaccine-and-category-type-1-covax\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/exam.pscnotes.com\/mcq\/"},{"@type":"ListItem","position":2,"name":"UPSC CDS-1","item":"https:\/\/exam.pscnotes.com\/mcq\/category\/upsc-cds-1\/"},{"@type":"ListItem","position":3,"name":"Consider the following pairs of vaccine and category\/type: 1. Covax"}]},{"@type":"WebSite","@id":"https:\/\/exam.pscnotes.com\/mcq\/#website","url":"https:\/\/exam.pscnotes.com\/mcq\/","name":"MCQ and Quiz for Exams","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/exam.pscnotes.com\/mcq\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/exam.pscnotes.com\/mcq\/#\/schema\/person\/5807dafeb27d2ec82344d6cbd6c3d209","name":"rawan239","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/exam.pscnotes.com\/mcq\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/761a7274f9cce048fa5b921221e7934820d74514df93ef195a9d22af0c1c9001?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/761a7274f9cce048fa5b921221e7934820d74514df93ef195a9d22af0c1c9001?s=96&d=mm&r=g","caption":"rawan239"},"sameAs":["https:\/\/exam.pscnotes.com"],"url":"https:\/\/exam.pscnotes.com\/mcq\/author\/rawan239\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/posts\/85313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/comments?post=85313"}],"version-history":[{"count":0,"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/posts\/85313\/revisions"}],"wp:attachment":[{"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/media?parent=85313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/categories?post=85313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/exam.pscnotes.com\/mcq\/wp-json\/wp\/v2\/tags?post=85313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}